Does TUCATINIB Cause Tumour marker increased? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Tumour marker increased have been filed in association with TUCATINIB (TUKYSA). This represents 0.2% of all adverse event reports for TUCATINIB.
13
Reports of Tumour marker increased with TUCATINIB
0.2%
of all TUCATINIB reports
1
Deaths
5
Hospitalizations
How Dangerous Is Tumour marker increased From TUCATINIB?
Of the 13 reports, 1 (7.7%) resulted in death, 5 (38.5%) required hospitalization.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TUCATINIB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does TUCATINIB Cause?
Diarrhoea (1,587)
Nausea (862)
Fatigue (843)
Vomiting (483)
Death (400)
Off label use (392)
Malignant neoplasm progression (361)
Palmar-plantar erythrodysaesthesia syndrome (355)
Product dose omission issue (332)
Asthenia (322)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which TUCATINIB Alternatives Have Lower Tumour marker increased Risk?
TUCATINIB vs TUCIDINOSTAT
TUCATINIB vs TYKERB
TUCATINIB vs TYLENOL
TUCATINIB vs TYROTHRICIN
TUCATINIB vs TYSABRI